: Absci stock rockets after collaboration with Merck could lead to more than 0 million in payments #FinanceUSA #StockMarketNEWS Shares of Absci Corp. skyrocketed 59.1% on heavy volume in premarket

@stockMarketNEWS Sun 09 Jan, 2022

Posted in: #FinanceUSA #StockMarketNEWS

Absci stock rockets after collaboration with Merck could lead to more than 0 million in payments #FinanceUSA #StockMarketNEWS
Shares of Absci Corp. skyrocketed 59.1% on heavy volume in premarket trading Friday, after the biotechnology company said it could be eligible to receive up to 0 million in upfront fees and milestone payments from Merck & Co. Inc. as part of a research collaboration agreement. Trading volume ballooned to 9.7 million shares, compared with the full-day average of about 324,800 shares, to make the stock the biggest gainer and most actively traded ahead of the open. Under the collaboration, Absci's Bionic Protein amino acid technology will be used to produce enzymes tailored to Merck's biomanufacturing platform. Merck also has the option to nominate up to three targets and enter into a drug discovery collaboration agreement. The stock, which closed at a record low of .14 on Thursday, had tumbled 42.9% over the past three months through Thursday, while the iShares Biotechnology ETF has shed 8.8% and the S&P 500 has gained 6.7%.

Munafa USA Munafa India Munafa NSE

Report

Login to post a comment!